EMILY BARTLER: Open Payments
NPI 1467090431 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$967 in 43 payments from 7 companies in 2025. Trend: 2023 $357 · 2024 $225 · 2025 $967
Food & beverage: $967
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 27 | $380 |
| Amgen Inc. | 6 | $174 |
| Edwards Lifesciences Corporation | 1 | $165 |
| Biosense Webster, Inc. | 3 | $85 |
| CARDIVA MEDICAL, INC. | 2 | $73 |
| HEARTFLOW, INC. | 3 | $69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
Products named: LEQVIO, SAPIEN 3 Ultra RESILIA, REPATHA, CARTO 3, CARDIVA VASCADE MVP VVCS 6-12F, FFRct, JARDIANCE.
Industry payments across PA — which companies pay providers there.
